Back to results
CompletedPhase 1

Pharmacokinetics of AGO178 in Participants With Liver Impairment

NCT01531309

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Orlando Clinical Research Center

Orlando, Florida, United States

View on ClinicalTrials.gov
Pharmacokinetics of AGO178 in Participants With Liver Impairment — TrialFind